Observational Study
Copyright ©The Author(s) 2025.
World J Psychiatry. May 19, 2025; 15(5): 100731
Published online May 19, 2025. doi: 10.5498/wjp.v15.i5.100731
Table 1 Comparisons of demographic characteristics in attention deficit and hyperactivity disorder children with or without speech and language therapy before propensity matching, n (%)
Variable
ADHD children
P value
Non-ST cohort (n = 9076)
ST cohort (n = 2911)
Gender0.2531
Girls2031 (22.4)622 (21.4)
Boys7045 (77.6)2289 (78.6)
Age at ADHD diagnosis (mean ± SD)5.99 (1.47)4.92 (1.54)< 0.0012
≥ 4 years1012 (11.2)809 (27.8)< 0.0011
> 4 years8064 (88.8)2102 (72.2)
Urbanization< 0.0011
1 (highest)3159 (34.8)881 (30.3)
22525 (27.8)753 (25.9)
31938 (21.4)570 (19.6)
41035 (11.4)313 (10.8)
5 (lowest)419 (4.6)394 (13.5)
Comorbidities
Cerebral palsy121 (1.3)229 (7.9)< 0.0011
Autism420 (4.6)712 (24.5)< 0.0011
Hearing loss569 (6.3)648 (22.3)< 0.0011
Delay development (including language or speech delay)2729 (30.1)2361 (81.1)< 0.0011
Mental retardation1035 (11.4)1063 (36.5)< 0.0011
Behavioral interventions< 0.0011
No4951 (54.6)1153 (39.6)
Yes4125 (45.4)1758 (60.4)
ADHD medication used< 0.0011
None4481 (49.4)1454 (49.9)
Methylphenidate HCL (Ritalin/Concerta)4574 (50.4)1450 (49.8)
Atomoxetine (Strattera)391 (4.3)184 (6.3)
Used 2 types370 (4.1)547 (4.6)